PH

Pakkarath Haleema

Active Director Whole-Time Director DIN 07603432
DIN 07603432 First appointment Nov 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Pakkarath Haleema

Data last updated:

Pakkarath Haleema is a Whole-Time Director at Arma Med Zity Private Limited (since 2016). The company operates in Business Services.

DIN 07603432
Primary Designation Whole-Time Director
Industry Business Services
First Appointment 04 Nov 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arma Med Zity Private Limited U74999KL2016PTC047201
Whole-Time Director04 Nov 20162016Active

Board colleagues of Pakkarath Haleema

NameDINCompanyDesignation
Oruvankunnath Sunil Sadath07603406Arma Med Zity Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Arma Med Zity Private Limited
Premium access

Shareholding and investment profile for Pakkarath Haleema

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pakkarath Haleema

Pakkarath Haleema currently holds 1 directorship: Arma Med Zity Private Limited (Whole-Time Director, since 04 Nov 2016).

Pakkarath Haleema was first appointed on 04 Nov 2016 as Whole-Time Director at Arma Med Zity Private Limited.

The current boards of Pakkarath Haleema's companies include Oruvankunnath Sunil Sadath (Arma Med Zity Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available